European Psychiatry - Volume 41

S798

25th European Congress of Psychiatry / European Psychiatry 41S (2017) S772–S846

EV1207

Approach in a mental health

hospitalization unit

M. Rodríguez

1 ,

∗

, V. Pérez

, D. Linares

, S. Jose María

Centre Hospitalier Torrecárdenas, Psychiatry, Almería, Spain

Centre Hospitalier Torrecárdenas, Psychology, Almería, Spain

∗

Corresponding author.

Introduction

The mental health hospitalization unit of Torrecár-

denas Hospital consist of a team of professional psychologists,

psychiatrists, nurses and occupational therapists who perform

different approaches to look after the hospitalized patient. The

therapeutic Objective of this unit is the containment and imple-

mentation of intensive interventions in a crisis situation in which

it has not been possible to achieve an improvement or control of

the patient’s symptoms in external resources.

Material and methods

We performed a descriptive cross-

sectional study with patients hospitalized at the mental health

hospitalization unit between September 22 and October 28, taking

into account the age, sex, admitted, diagnoses, previous treatments,

psychological approach and free hospital stay.

Results

( Figures 1–3 ).

Conclusions

The results of this study indicate the most prevalent

patient profile has a diagnosis of severe mental disorder. The 66.7%

of patients had previous hospital admissions. The 81.5% of hospital

admissions are involuntary. The normative psychopharmacological

prescription is an atypical antipsychotic as main treatment in our

study. We highlight the use of Olanzapine with an 18.52% being

consolidated as the first therapeutic option. As adjunctive treat-

ment we have amood stabilizer such as Valproic Acidwith 11.1%; or

another antipsychotic such as Paliperidone with the same percent-

age (11.1%). Regarding hypnotic treatment, it should be pointed

out the use of medium-life benzodiazepines (Lormetazepam) with

a prevalence of 55.56%.

Fig. 1

Fig. 2

Fig. 3

Disclosure of interest

The authors have not supplied their decla-

ration of competing interest.

http://dx.doi.org/10.1016/j.eurpsy.2017.01.1537

EV1208

The genetic methods for

drug-resistant epilepsy

M. Salohiddinov

Tashkent Medical Academy, Psychiatry and narcology, Boyovut,

Uzbekistan

Actuality

Mechanisms of underlying pharmacoresistance have

been explored insufficiently. Enzymes of a system for biotrans-

formation of xenobiotic and transporters for drugs are the key

participants in the systems of metabolism of antiepileptic drugs

(AEDs). Among proteins-transporters, glycoprotein P encoded by

MDR1 gene plays an essential role in the processes of uptake, dis-

tribution and excretion of AEDs.